The first colposcopy workshop was conducted by renowned and acclaimed faculty Dr Priya Ganeshkumar at the New Ramakrishna Sevasadan Hospital, Siliguri.
Current estimates indicate that every year 123907 women are diagnosed with cervical cancer and 77348 die from the disease.
One of the most effective tools in the fight against cervical cancer is the colposcopy procedure."
Alok Khettry, COO, India Business, BSV, said, “India is taking bold steps towards eradicating cervical cancer with a range of preventive measures.
Colposcopy enables healthcare providers to identify abnormal cervical cells early, often before they develop into cancer.
First-of-its kind workshop at the New Ramakrishna Sevasadan Hospital, Siliguri
Bharat Serums and Vaccines Limited (BSV), Mumbai-vased biopharmaceutical company, has partnered with the Public Awareness Committee, Federation of Obstetric and Gynaecological Societies of India (FOGSI) to increase awareness and access of colposcopy, a diagnostic method that allows for detailed examination of the cervix, vagina, and vulva, in the early detection of precancerous changes and cervical cancer.
The first colposcopy workshop was conducted by renowned and acclaimed faculty Dr Priya Ganeshkumar at the New Ramakrishna Sevasadan Hospital, Siliguri. The workshop, which is the first-ever attempt in a Tier 2 city aimed to enhance awareness among several gynaecologists and specialists on the importance of colposcopy in the early detection and accurate diagnosis of cervical cancer.
Speaking on the initiative, Dr Priyankur Roy, Chairperson, Public Awareness Committee, FOGSI, said, “Ranked as the second most frequent cancer among women in India between15 and 44 years of age, cervical cancer remains a significant public health concern in India. Current estimates indicate that every year 123907 women are diagnosed with cervical cancer and 77348 die from the disease. One of the most effective tools in the fight against cervical cancer is the colposcopy procedure."
Alok Khettry, COO, India Business, BSV, said, “India is taking bold steps towards eradicating cervical cancer with a range of preventive measures. As a dedicated women’s health company, we are committed to spearheading initiatives that raise awareness and widen access to preventive care, promoting the health and well-being of women. Our role as a leading biopharma company driven by research, goes beyond treatment. We aim to educate our stakeholders through continued scientific knowledge-sharing, even while we are not present in the management or treatment of such diseases."
Colposcopy enables healthcare providers to identify abnormal cervical cells early, often before they develop into cancer. When a Pap smear test indicates abnormal results, colposcopy provides a more accurate follow-up examination. It allows for biopsies of any suspicious areas, ensuring that any abnormal cells are detected and treated promptly.
